Novel Medical's "Domestic Dual-Head Variable-Angle Diagnostic-Grade SPECT/CT Prototype" project recently received an "excellent" evaluation in the project acceptance organized by the National Nuclear Security Administration. This recognition not only affirms Novel Medical's technical strength but also strongly promotes the development of the domestic high-end medical equipment industry.
Champion of Localization Strategy
In response to the long-standing reliance on imported medical imaging equipment, Novel Medical actively supports national initiatives by accelerating the localization process. We understand that localization is not only a national strategy but also a crucial way to enhance medical service quality and reduce costs.
Technical Breakthroughs and Industry Innovation
Novel Medical has successfully overcome key technical challenges in SPECT/CT, filling the domestic gap and achieving performance indicators that meet international standards. Its clinical applications can further improve the diagnosis of cancer, ischemic heart disease, and kidney disease, continuously advancing the high-quality development of the nuclear medical industry.
Social Responsibility and Healthy China
Novel Medical prioritizes social responsibility and actively develops high-end domestic medical imaging equipment. With ongoing technological advancements and expanding applications, SPECT/CT will play a significant role in providing doctors with more accurate and comprehensive imaging information, helping patients detect diseases earlier and develop more precise treatment plans.
Future Outlook
Looking ahead, Novel Medical will continue to uphold its core values of "integrity, responsibility, perseverance, and ownership." We will increase R&D investment, drive technological innovation and industrial upgrades, and continuously improve product performance and quality, contributing more to the self-sufficiency of China's high-end medical equipment.
Language
